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Background
The repair and regeneration of bone is a complex interplay between the ground substance, 
cells and milieu, but is still not fully comprehended [1]. Although autologous bone grafts 
have been used successfully for many bone disorders for some time now, it is not always 
practical and can be challenging in harvesting sufficient graft material and causes trauma 
to the donor site.
There are alternative materials to autologous bone grafts currently used in various 
bone repairs that have yielded some success. However, there are many technical prob-
lems and the osteogenic effect of such alternatives is still not satisfactory [2, 3]. Natural 
biological materials such as collagen, chitosan and others have problems such as poor 
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mechanical strength, immunogenicity, non-osteoconductivity or non-osteoinducive, 
inappropriate degradation time or poor reproducibility [4, 5].
Organic polymers such as poly(lactic acid), poly(glycolic acid), poly(ε-caprolactone) 
and poly(lactic-co-glycolic acid) copolymers have insufficient mechanical strength and 
are poorly hydrophilic. Degradation of some organic polymers causes acidic conditions 
that result in inflammation. These materials also have weak adsorption of cells and more 
importantly: lack cell surface recognition signals and interaction with the biological tis-
sue. In addition, they are still expensive and have unsatisfactory plasticity [1, 6].
With inorganic materials such as β-tricalcium phosphate, hydroxyapatite, and bioac-
tive glass, the scaffold resorption rate exceeds the bone formation rate and cannot main-
tain repair function. Others absorb too slowly or not at all, can produce foreign body 
reactions after implantation, are not conducive to new bone remodeling and their pro-
duction method cannot guarantee consistent pore connectivity [1, 7]. Therefore, alterna-
tives to autogenous bone graft material to accelerate the repair of bone defects has been 
an important issue faced by orthopedic surgeons.
Calcium phosphate has been commonly used as a substitute scaffold in bone tissue 
engineering, but easily becomes brittle, has poor degradation performance and absorbs 
poorly, affecting the formation of new bone and later development [8, 9]. However, 
silicon-substituted calcium phosphate (Si-CaP) has been found to have good biocom-
patibility, biodegradability and osteoconduction [10, 11]. The addition of silicone to cal-
cium phosphates causes changes in the structural properties of the scaffolding material 
and significantly improves bioactivity. These materials become fully absorbed by bone 
cells and are replaced by natural bone during bone remodeling [12, 13]. Several stud-
ies [14–20] have shown that, compared with a pure calcium phosphate, Si-CaPs have 
the following advantages: (1) good degradation performance, (2) higher biological activ-
ity, (3) supports the migration of bone cells and their differentiation and (4) can reduce 
cell damage caused by environmental changes. Si-CaP is a new scaffold with good pros-
pects. However, although Si-CaP is osteoconducive, it is not osteoinducive [21], which is 
a major shortcoming of autogenous bone graft substitute materials. Creating a scaffold 
that is combined with a substance that is involved in osteoinduction may increase the 
osteogenic potential of the graft substitute material. Studies have shown that fine parti-
cles of bone accelerate healing compared to traditional bone grafts [22]. However, since 
such particles of lose bone structure easily drain, are difficult to mold and have other 
shortcomings, the application is limited. Therefore, we focused on ways to overcome the 
respective shortcomings of Si-Cap and fine bone particles in bone repair. To do this, we 
investigated the potential of viable osteoblasts in fine particulate bone powder (FPBP) to 
provide osteoinductive and osteogenic properties to the osteoconductive Si-CaP in the 
combination scaffold: Si-CaP/FPBP, as a tentative method for bone-defect repair.
Methods
Synthesis and identification of Si‑CaP
Three-dimensional porous Si-CaP tubes were prepared using aqueous precipitation 
method as described previously [23]. The tubes had an inside diameter, outside diameter 
and length of 0.6, 1 and 1.5 cm, respectively and weighed 1.5 g. The crystal phase composi-
tion of Si-CaP was studied with X-ray diffraction, using a D/MAX-Rb X-ray diffractometer 
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(Rigaku, Japan) with Ni-filtered Cuka radiation operated at 30 kV and 10 mA at a scanning 
speed of 1/min. Si-CaP functional groups were detected by Nicolet710 Far-infrared Fou-
rier transform spectroscopy (Thermal, United States) with a frequency range from 4,000 
to 400 cm−1 and a resolution of 2 cm−1. Si-CaP microstructure and elemental composition 
was analyzed using a dual beam focused ion beam scanning electron microscopy (FIB-
SEM) system (HELIOS NanoLab 600i, FEI, Netherlands) equipped with an energy disper-
sive X-ray spectroscopy (EDS) unit operated at 20 kV. Liquid displacement methodology 
was used to measure the porosity of Si-CaP as described previously [24].
Preparation of fine particulate bone powder
Animal study was approved by the Institutional Animal Care and Use Committee of Har-
bin Medical University (Protocol: 2012-002). FPBP was prepared from New Zealand white 
rabbits (6 months old, 2.5 kg). Briefly, iliac crest bone (1 g) was first ground using an elec-
tric ball mill drill (BJ2103, Bojin, China). Particles of 300–500 μm were isolated using a 
sub-sieve sizer and centrifuged at 120 rpm for 5 min (Eppendorf, Germany). Light micros-
copy (DVM2500, Lecia, Germany) and scanning electron microscopy (SEM) (HELIOS 
NanoLab 600i, FEI, Netherlands) were used to characterize the general and surface mor-
phology of FPBP particles.
Construction of Si‑CaP/FPBP scaffold
To prepare Si-CaP/FPBP scaffolds, Si-CaP and FPBP were mixed at a 1:1 weight ratio and 
packed into 1.6 cm3 tubes (diameter: 0.92 cm, height: 2 cm). An example of the scaffold 
is shown in Figure 1a. Si-CaP, FPBP and Si-CaP/FPBP scaffolds were then subjected to in 
vitro degradation tests at 37°C. Experiments were divided into three groups: Si-CaP group, 
FPBP and Si-CaP/FPBP. Si-CaP tubes were filled with FPBP at a weight ratio of 1:1 (0.75 g 
of each component). Bone scaffolds were cultured in six well culture plates containing 
Figure 1 The Si-CaP/FPBP tube (a), and the: changes of pH (b), weight (c), water absorption ability (d), com-
pression strength (e) and elastic modulus (f) after the scaffolds were soaked in DMEM medium for different 
time periods. n = 7. **p < 0.01 compared to Si-CaP group.
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15 ml DMEM culture medium (pH 7.4) (Invitrogen, USA). Bone scaffolds were incubated 
at 37°C for 3, 7, 14 and 28 days.
pH measurement
The pH change of the culture medium was detected with pH meter at each at 0, 3, 7, 14 
and 28 days of incubation. Each average pH value was obtained from seven measurements 
taken under the same testing conditions. Experiments were performed in seven replicates.
Weight loss
To measure the weight changes, scaffolds were removed from the culture plates at 0, 3, 7, 
14 and 28 days of incubation, rinsed with water and dried for 24 h with a blow dryer. The 
weight loss values were measured using an electronic balance with an accuracy of 0.001 g. 
The weight loss ratio was calculated from the equation:
where M0 is the weight of scaffolds before degradation and M1 is the weight of dried 
scaffolds after degredation. Each average weight loss value was obtained from seven 
measurements taken under the same testing conditions. Experiments were performed in 
seven replicates.
Water absorption
Water absorption was measured at 0, 3, 7, 14 and 28 days of incubation. To measure the 
water absorption, scaffolds were removed from the culture plates and blotted dry on fil-
ter paper to remove excess water. The water absorption was measured using an electronic 
balance with an accuracy of 0.001 g. The water absorption ratio was calculated from the 
equation:
where M2 is the weight of scaffolds with excess water removed. Each average water 
absorption value was obtained from seven measurements taken under the same testing 
conditions. Experiments were performed in seven replicates.
Compressive strength measurement
The compressive strengths of the scaffolds were determined using Electronic Universal 
Testing Machine (Instron 5500R, United States) with a crosshead speed of 1.0 mm/min. 
To conduct the test, the scaffolds were removed from the culture plates, rinsed with deion-
ized water and dried thoroughly using a blow dryer. The load was recorded as compres-
sive strength (MPa) at the point where the scaffold fractured. The elastic modulus (MPa) 
was determined by the slope of the initial linear portion of the stress–strain curve. Each 
average value was obtained from seven measurements taken under the same testing condi-
tions. Experiments were performed in seven replicates.
weight loss ratio (%) = (M0 −M1)/M0 × 100,
water absorption ratio (%) = (M2 −M0)/M0 × 100,
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Surface morphology
The surface morphology of scaffolds were observed using FIB-SEM. Briefly, the scaffolds 
were removed from the culture plates, fixed with 2.5% glutaraldehyde solution (pH 7.4) 
(Sigma Chemical Co., USA) for 24 h at 4°C and then for 30 min in 1% osmium tetroxide 
(Sigma Chemical Co.). The scaffolds were dehydrated in a graded series of ethanol, criti-
cally point dried with CO2 and sputtered with gold.
H&E staining
For H&E staining, nuclei was stained with alum haemtoxylin for 10 min and differentiate 
with 0.3% acid alcohol for 2 s. Then, samples were rinsed in Scott’s tap water substitute and 
stained with eosin for 2 min. Finally, slides were dehydrated and mounted with permount 
medium.
Statistical analysis
All values were expressed as mean ± standard deviation. Differences among groups were 
analyzed by ANOVA followed by Bonferroni post hoc analyses as appropriate, using SPSS 
17.0 statistical software. A p value of <0.05 was considered significant.
Results
Synthesis and identification of Si‑CaP
X-ray diffraction analysis showed that synthesized Si-CaP was homogenous and single 
phase material with all peaks matching with standard Si-CaP diffraction peaks provided 
by the International Centre for Diffraction Data (Figure  2a). Far-infrared Fourier trans-
form spectroscopy analysis of two batches of Si-CaP exhibited same absorbance spectrum 
with major bands at 1,125 and 692 cm−1, demonstrating the repeatability of this synthesis 
method (Figure 2b). The images obtained from FIB-SEM showed rod or spherical shapes 
of Si-CaP particles with small Si-CaP crystals clustered on the surface (Figure  3a–c). 
Nanoscale pores with irregular sizes and shapes, formed by Si-CaP crystal clusters, were 
present on particle surfaces. Macropores of 150–300 µm were evenly distributed and con-
nected by micropores of 1–10 µm throughout the scaffolds. EDS point analysis detected 
8% silicon in the Si-CaP (Figure  3d; Table  1). Additionally, as determined by liquid dis-
placement methodology, the average porosity of Si-CaP was 74.144 ± 3.833%.
Preparation and characterization of FPBP
Bright field images showed that FPBP particles had irregular shape with bone debris scat-
tered on the surface (Figure 4a). SEM was used to characterize the surface morphology of 
FPBP (Figure 4b, c). The FPBP was observed as a mixture of 10 μm porous cortical and 
cancellous bone. The majority was coarse cancellous bone.
Preparation and characterization of Si‑CaP/FPBP scaffold
An example of the obtained Si-CaP/FPBP tubes is shown in Figure 1a.
pH change
The pH of DMEM solution during the in vitro degradation of three types of scaffolds was 
first determined. As degradation time increased, the pH of the DMEM solution in all three 
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groups increased. The pH values of Si-CaP degradation solution were slightly higher than 
that of Si-CaP/FPBP degradation solution, but with no significant difference (P  >  0.05). 
However, the pH values of both Si-CaP and Si-CaP/FPBP degradation solutions were sig-
nificantly higher than the pH value of the FPBP solution (Figure 1b, P < 0.05).
Weight loss
As shown in Figure 1c, Si-CaP and Si-CaP/FPBP scaffolds experienced dramatic weight 
loss during the 28 days of incubation. Si-CaP scaffolds degraded significantly faster than 
Si-CaP/FPBP composite scaffolds between days 3 and 14. In contrast, the FPBP group 
experienced significantly slower weight loss than both Si-CaP and Si-CaP/FPBP groups 
(P < 0.05).
Changes in water absorption
The water absorption of Si-CaP and Si-CaP/FPBP scaffolds can be divided into two phases 
during the in vitro degradation process: 0–3 days, water absorption increased significantly, 
Figure 2 a X-ray diffraction spectrum of Si-CaP powder. b Far-infrared Fourier transform spectroscopy analy-
sis of two batches (1, 2) of Si-CaP powder sintered at 1,200°C for 4 h.
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and 3–28 days, water absorption appeared to decrease slowly. In contrast, water absorp-
tion by FPBP increased slowly, and after 14  days apparent water absorption did not 
change significantly. Overall, scaffolds in Si-CaP/FPBP group had the highest water uptake 
amongst the three groups (Figure  1d). However, water absorption was assessed by dif-
ferences in weight and after 3 days, change in weight is likely due to scaffold-dissolution, 
rather than loss of absorbed water.
Figure 3 SEM images of Si-CaP powder at 200× (a), 1,000× (b) and 10,000× (c) magnification. d EDS profile 
of Si-CaP powder surface at the spot indicated in a.







Figure 4 a Light microscope image of FPBP. FPBP particle sizes were about 300–500 µm. b, c SEM images of 
FPBP at 200× (b) and 1,000× (c).
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Compressive strength
The change in compressive strength of Si-CaP, Si-CaP/FPBP and cortical bone (CB) was 
measured and compared (Figure  1e). The strength of scaffolds in each group continu-
ously decreased during the 28 day period. Before in vitro degradation, the average com-
pression strength of Si-CaP/FPBP, Si-CaP and CB was 1.288 ± 0.107, 0.614 ± 0.130 and 
1.200 ± 0.130 MPa, respectively. Before degradation, the compression strength of Si-CaP/
FPBP scaffolds was significantly higher than that of Si-CaP scaffolds, but lower than that of 
CB blocks (P < 0.05).
Elasticity modulus
Before in vitro degradation, the elasticity modulus of Si-CaP/FPBP, Si-CaP and CB blocks 
were 149.705 ± 7.414, 43.033 ± 3.933 and 143.976 ± 4.630 MPa, respectively. The elastic-
ity modulus of scaffolds in Si-CaP, Si-CaP/FPBP groups continuously decreased over the 
28 days. As shown in Figure 1f, the elasticity modulus of Si-CaP was significantly lower 
than the Si-CaP/FPBP. The elasticity modulus of Si-CaP/FPBP scaffolds was slightly lower 
than CB blocks, but not significantly different (P > 0.05).
SEM observation of scaffolds
Cross-section surface morphology of Si-CaP/FPBP scaffold was observed with SEM before 
in vitro degradation. We found that FPBP attached tightly to the surface of Si-CaP par-
ticles (Figure 5a). Si-CaP particles showed uniform short rod shape with size of approxi-
mately 2–10 µm. Si-CaP particles and FPBP were relatively uniform and positioned closely 
together. The Si-CaP/FPBP scaffold formed three-dimensional porous structures. The sizes 
of pores were approximately 150–300 µm with micropores of 1–10 µm distributed on the 
relatively smooth pore wall.
Figure 5 SEM images of Si-CaP/FPBP at day 0 (a), 3 (b), 7 (c), 14 (d), and 28 (e) days in vitro degradation. 
n = 7.
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After 3  days degradation in DMEM medium, we found Si-CaP/FPBP scaffolds par-
tially degraded and single small spherical particles deposited on the scaffold surface 
 (Figure 5b). Each spherical particle was composed of several apatite crystals, observed 
by high-powered microscopy (data not shown). The Si-CaP and FPBP scaffolds showed 
no change (data not shown). At 7 days of in vitro incubation, we found the cell wall of 
Si-CaP/FPBP scaffold was degraded. Lamellar bone-like apatite had formed on the scaf-
fold surface and a large number of small bone-like apatite particles were deposited on 
the pore wall (Figure 5c). At the same time point, Si-CaP and FPBP scaffolds surface was 
only slightly degraded. At 14 days of in vitro incubation, a large number of loose, spheri-
cal or short rod-like bone-like apatite particles had deposited on the surface of Si-CaP/
FPBP scaffolds (Figure 5d). Finally, at 28 days, a large number of regular lamellar bone-
like apatite particles with size approximately 0.2–1  µm were observed on the Si-CaP/
FPBP surface (Figure 5e).
H&E observation
H&E observation found that Si-CaP and FPBP engaged tightly with each other at the inter-
face on day 0. As time increased, Si-CaP at the junction between Si-CaP and FPBP became 
sparse and loose. Lacunae gradually became empty. After 14 days of in vitro incubation, 
osteoblasts had lyzed and disappeared (Figure 6a–e).
Discussion
Calcium phosphates are the most frequently used materials in bone substitutions today, 
due to their similarity to natural inorganic compounds in bone [25–27]. Patel et al. [28] 
showed that incorporation of silicate ions into hydroxyapatite significantly improves bio-
activity. Here, we show that the combination of fine bone particles with silicone-calcium 
phosphate, further improves the performance of the scaffold.
Figure 6 H&E images of Si-CaP/FPBP at day 0 (a), 3 (b), 7 (c), 14 (d), and 28 (e) days in vitro degradation. 
n = 7.
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Degradation and mechanical properties of Si‑CaP/FPBP in vitro
Tuck et al. [25] performed a degradation experiment with Si-CaP in deionized water at a 
1:30 mass to volume ratio. After 30 days, the pH of the water had increased from 7.4 to 
approximately 9 and stabilized there. Analysis by multiple methods showed that  Si-CaP 
had good degradation performance and formed bone-like apatite in vitro. Similarly, the 
pH of the DMEM for the Si-CaP/FPBP group and the Si-CaP group in our experiment 
also increased significantly over time and reached approximately 9 after 28 days. FPBP 
alone only had a modest increase in pH. This change is mainly due to the interaction 
of oxygen in the phosphate group of the Si-CaP surface with water, producing hydrox-
ide. The reaction is as follows: PO43− +  H2O =  HPO42− +  OH− [25]. Further to this, 
the dissolution of Si-CaP releases Ca2+ into the DMEM culture medium as the charge-
compensating Si-CaP absorbs two H+ ions, resulting in the pH of the DMEM culture 
increasing further [25]. The pH of Si-CaP/FPBP group was lower than the pH of Si-CaP 
group throughout the entire degradation process. This may be due to the interaction of 
Si-CaP with FPBP making the overall degradation rate relatively low and closer to oste-
ogenesis. The surface of Si-CaP/FPBP scaffold degraded completely after 7  days and 
increasingly formed apatite deposition over the 28 days. The surface of FPBP and Si-CaP 
scaffolds had degraded slightly at 7 days of incubation with the deposition of some bone-
like apatite particles, but there was no significant change after 28 days. This may be due 
the hydroxyapatite slowly dissolving and escaping from the FPBP. The ability of a scaffold 
to bond to the living material that surrounds it, as well as maintaining non-acid condi-
tions, is essential to the healing process. The cross-linking of collagen chains during bone 
formation requires alkaline conditions [29]. Formation of bone-like apatite on the surface 
of a bone-substitute scaffold is crucial to bone-bonding and facilitates osteoblast adhe-
sion and proliferation. In vitro evaluation of a material’s apatite-forming ability also cor-
relates well with its bone-bonding ability in vivo. Therefore, making in vitro observations 
of apatite formation is a useful way of preliminary screening of new scaffolding materials 
before in vivo assessment [28, 30, 31].
The weight loss of the Si-CaP, FPBP and Si-CaP/FPBP groups increased continually as 
incubation time increased, indicating that the three groups of materials degraded con-
tinually in DMEM. At 0–3 days of incubation, the degradation of the amorphous region 
of the amorphous phase in the Si-CaP group and Si-CaP/FPBP group resulted in the 
release of large amounts of degradation products, such as PO43− and Ca2+, and caused 
weight loss to increase rapidly in the Si-CaP and Si-CaP/FPBP group. However, after 
3 days incubation, plasma PO43− and Ca2+ reached heterogeneous nucleation sites and 
formed bone-like apatite depositions, resulting in decreased weight loss in the Si-CaP 
and Si-CaP/FPBP group [32]. In the period between 3 and 14 days, the FPBP of Si-CaP/
FPBP group degraded and released hydroxyapatite particles that deposited on the sur-
face of the scaffold reducing the weight loss in the Si-CaP/FPBP group compared to the 
Si-CaP group. The lower rate of weight loss of the Si-CaP/FPBP may be due to dense 
tissue structure, the presence of hydrophobic material and highly crystalline inorganic 
components.
Water absorption in the Si-CaP, FPBP and Si-CaP/FPBP groups increased over the 
first 3 days. This is probably due to a large amount of hydroxyl within the surface and 
internal pore wall of these porous structures which attracts water molecules through 
Page 11 of 14Sun et al. BioMed Eng OnLine  (2015) 14:47 
the process of hygroscopy [25]. Additionally, the Si-CaP group, FPBP group and Si-
CaP/FPBP group had multiple micropores connected to each other, forming a capil-
lary network structure which may absorb water by capillary action [33, 34].
The ideal autologous bone substitution materials must have good mechanical per-
formance and changes in mechanical strength of autologous bone substitute materials 
should match the growth rate of bone tissue [35]. In our experiment the compressive 
strength and elastic modulus of the Si-CaP/FPBP group and cancellous bone group was 
significantly higher than that of the Si-CaP group and throughout the in vitro degra-
dation process, there was no significant difference in compressive strength and elastic 
modulus between Si-CaP/FPBP group and cancellous bone group. This indicates that 
the addition of fine bone particles can make homogeneous composite scaffolds signifi-
cantly more stress resistant. The elastic modulus of the composites was also improved 
by the addition of FPBP, which is advantageous in surgical applications. In addition, we 
observed by SEM that Si-CaP and FPBP distributed uniformly and combined to a well-
knit interface. This combination and distribution at the interface provides a structural 
basis for good mechanical properties of Si-CaP/FPBP. Our results show that FPBP affects 
the degradation rate of the Si-CaP and improves its mechanical strength. Throughout 
the degradation process, the change in pH, weight loss, water absorption and mechani-
cal strength indicates that Si-CaP/FPBP had better degradation and mechanical proper-
ties than Si-CaP alone.
Morphology and structure of Si‑CaP/FPBP
The microstructures of porous scaffolds have been shown previously to play a vital role in 
new bone growth, and a pore size of at least 100 µm is a requirement for complete biologi-
cal activity [36, 37]. One study reported that a scaffold exhibited osteoconductive proper-
ties when the pore size was larger than 200 μm [38]. Kang et al. [39] showed that a scaffold 
with 57% of porosity and pore size of 100–250 μm had good in vitro degradation perfor-
mance and formed bone-like apatite. Zhuang et al. [40] found that scaffolds with 36–55% 
porosity and pore size of 200–400 μm had good mechanical properties and a controlled 
degradation rate.
The Si-CaP/FPBP scaffold constructed in our experiment had a three-dimensional 
porous structure with pore size about 150–300  μm (“macropores”) and porosity 
of 75%. Macropores guide the growth of cells and blood vessel on the wall of the 
pore, which increases osteoconductive performance of the scaffold and bone tissue 
growth into the internal scaffold [41, 42]. In addition to macropores, micropores of 
approximately 1–10 μm were observed in the pore walls, by SEM. These micropores 
were channels that interconnected the larger pores of the Si-CaP/FPBP with good 
connectivity. Micropores have also been previously found to play important roles 
in osteogenesis. Yuan et  al. [37] found that calcium phosphate scaffolds lacking 
micropores do not exhibit bone in-growth in dogs, and it is believed that micropo-
res facilitate protein interaction, cell attachment, cellular development and orienta-
tion and directionality of cellular growth [43, 44]. Although micropores are not the 
osteogenic agent itself, their presence results in larger surface area which probably 
results in more protein absorption (for example BMP), and also ion exchange and 
apatite formation by dissolution and reprecipitation [37]. BMP is known to induce 
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bone-formation in a dose-dependent manner with a local concentration threshold 
and a rough surface facilitates attachment, proliferation and differentiation of bone 
forming cells [37].
During the in vitro degradation process, porosity of Si-CaP/FPBP increased, the 
pore wall degraded, micropores formed and connectivity between pores increased. A 
small amount of bone-like apatite formation was observed on the surface of Si-CaP at 
the seventh day of degradation in DMEM culture medium. This was consistent with 
the reported literature in which low crystallization apatite was observed on Si-CaP 
on the seventh day of degradation in simulated body fluid [28]. Compared with the 
 Si-CaP, Si-CaP/FPBP had a more rapid formation of bone-like apatite. The formation 
of apatite is a natural event in bone formation and important for bioactivity and dif-
ferences in apatite formation rate between different Si-CaP scaffolds affects bioactiv-
ity [45].
Biological properties of Si‑CaP/FPBP
In our experiment, the complete structure of osteoblasts in Si-CaP/FPBP was observed 
by H&E staining. After in vitro degradation for 14 days, the osteoblasts had dissolved 
and disappeared. In vivo studies have also shown that FPBP participates in all stages 
of bone defect repair,plays roles in osteogenesis [46]. Thus the addition of FPBP to 
 Si-CaP should improve the biological activity of the scaffold and our findings support 
this idea.
Our data taken together and with the support of other works, show that a scaffold com-
prised of a porous Si-CaP structure packed with fine particles of bone provides a mileu 
conducive to osteogenesis, bone-bonding and bone repair, whilst maintaining mechani-
cal strength and elastic modus. Although we only performed in vitro experiments in our 
studies, others have shown that such assessments correlate well with in vivo observations. 
Hence we expect the Si-CaP/FPBP scaffold will also perform well in vivo.
Conclusions
Si-CaP and FPBP have both been shown previously to have properties that can facilitate 
bone-repair. However, individually these materials are insufficient for sustaining bone 
remodeling. Scaffolds constructed from a combination of the two, on the other hand, may 
collectively possess the required characteristics for efficient bone-repair. In this study, we 
found that FPBP enhances the performance of a silicate-substituted calcium-phosphate 
scaffold. We believe that Si-CaP/FPBP scaffolds may possess the necessary characteristics 
required of an autologous bone graft substitute for successful bone-repair.
Abbreviations
CB: cortical bone; FIB-SEM: focused ion beam scanning electron microscopy; FPBP: fine particulate bone powder; Si-CaP: 
silicon-substituted calcium phosphate.
Authors’ contributions
CS, YT, XW conceived and designed the study; CS, YT, WX, CZ and HX performed the experiments; CS, YT and WX analyzed 
the data; and CS, YT and XW jointly prepared the manuscript. All authors read and approved the final manuscript.
Author details
1 Department of Orthopaedic Surgery, The Second Harbin City Hospital, Harbin 150056, China. 2 Department of Orthopaedic 
Surgery, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Street, Nangang District, Harbin 150086, 
China. 
Page 13 of 14Sun et al. BioMed Eng OnLine  (2015) 14:47 
Acknowledgements
This study was supported by the National Natural Science Foundation of China (Grant Nos. 81371977, 81272014) and 
Science and Technology Research Project of Heilongjiang Province, Department of Education (Grant No. 12521222). 
The authors would like to thank the technical help from the Key Laboratory of Myocardial Ischemia of Harbin Medical 
University, Ministry of Education, Heilongjiang Province, China.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 7 November 2014   Accepted: 21 April 2015
References
 1. Szpalski C, Wetterau M, Barr J, Warren SM. Bone tissue engineering: current strategies and techniques—part I: scaf-
folds. Tissue Eng Part B Rev. 2012;18(4):246–57.
 2. Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future directions. BMC 
Med. 2011;9:66.
 3. Venugopal J, Prabhakaran MP, Zhang Y, Low S, Choon AT, Ramakrishna S. Biomimetic hydroxyapatite-con-
taining composite nanofibrous substrates for bone tissue engineering. Philos Trans A Math Phys Eng Sci. 
1917;2010(368):2065–81.
 4. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury. 2005;36(Suppl 3):S20–7.
 5. Venkatesan J, Kim SK. Chitosan composites for bone tissue engineering—an overview. Mar Drugs. 
2010;8(8):2252–66.
 6. Theler JM. Bone tissue substitutes and replacements. Curr Opin Otolaryngol Head Neck Surg. 2011;19(4):317–22.
 7. Bose S, Roy M, Bandyopadhyay A. Recent advances in bone tissue engineering scaffolds. Trends Biotechnol. 
2012;30(10):546–54.
 8. Kamitakahara M, Ohtsuki C, Miyazaki T. Review paper: behavior of ceramic biomaterials derived from tricalcium 
phosphate in physiological condition. J Biomater Appl. 2008;23(3):197–212.
 9. Hammouche S, Hammouche D, McNicholas M. Biodegradable bone regeneration synthetic scaffolds: in tissue 
engineering. Curr Stem Cell Res Ther. 2012;7(2):134–42.
 10. Coathup MJ, Samizadeh S, Fang YS, Buckland T, Hing KA, Blunn GW. The osteoinductivity of silicate-substituted 
calcium phosphate. J Bone Joint Surg Am. 2011;93(23):2219–26.
 11. Jenis LG, Banco RJ. Efficacy of silicate-substituted calcium phosphate ceramic in posterolateral instrumented lumbar 
fusion. Spine. 2010;35(20):E1058–63.
 12. Gillespie P, Wu G, Sayer M, Stott MJ. Si complexes in calcium phosphate biomaterials. J Mater Sci Mater Med. 
2010;21(1):99–108.
 13. Hoppe A, Guldal NS, Boccaccini AR. A review of the biological response to ionic dissolution products from bioactive 
glasses and glass-ceramics. Biomaterials. 2011;32(11):2757–74.
 14. Maehira F, Miyagi I, Eguchi Y. Effects of calcium sources and soluble silicate on bone metabolism and the related 
gene expression in mice. Nutrition. 2009;25(5):581–9.
 15. Honda M, Kikushima K, Kawanobe Y, Konishi T, Mizumoto M, Aizawa M. Enhanced early osteogenic differentiation 
by silicon-substituted hydroxyapatite ceramics fabricated via ultrasonic spray pyrolysis route. J Mater Sci Mater Med. 
2012;23(12):2923–32.
 16. Lehmann G, Cacciotti I, Palmero P, Montanaro L, Bianco A, Campagnolo L, et al. Differentiation of osteoblast and 
osteoclast precursors on pure and silicon-substituted synthesized hydroxyapatites. Biomed Mater. 2012;7(5):055001.
 17. Cameron K, Travers P, Chander C, Buckland T, Campion C, Noble B. Directed osteogenic differentiation of human 
mesenchymal stem/precursor cells on silicate substituted calcium phosphate. J Biomed Mater Res Part A. 
2013;101(1):13–22.
 18. Gomes PS, Botelho C, Lopes MA, Santos JD, Fernandes MH. Evaluation of human osteoblastic cell response to 
plasma-sprayed silicon-substituted hydroxyapatite coatings over titanium substrates. J Biomed Mater Res B Appl 
Biomater. 2010;94(2):337–46.
 19. Guth K, Campion C, Buckand T, Hing KA. Surface physiochemistry affects protein adsorption to stoichiometric and 
silicate-substituted microporous hydroxyapatites. Adv Eng Mater. 2010;12(4):B113–21.
 20. Guth K, Campion C, Buckland T, Hing KA. Effect of silicate-substitution on attachment and early development of 
human osteoblast-like cells seeded on microporous hydroxyapatite discs. Adv Eng Mater. 2010;12(1–2):B26–36.
 21. Hak DJ. The use of osteoconductive bone graft substitutes in orthopaedic trauma. J Am Acad Orthop Surg. 
2007;15(9):525–36.
 22. Sun YX, Sun CL, Tian Y, Xu WX, Zhou CL, Xi CY, et al. A comparison of osteocyte bioactivity in fine particulate bone 
powder grafts vs larger bone grafts in a rat bone repair model. Acta Histochem. 2014;116(6):1015–21.
 23. Gibson IR, Best SM, Bonfield W. Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res. 
1999;44(4):422–8.
 24. Calvo JI, Bottino A, Capannelli G, Hernandez A. Comparison of liquid–liquid displacement porosimetry and scan-
ning electron microscopy image analysis to characterise ultrafiltration tracketched membranes. J Membr Sci. 
2004;239(2):189–97.
 25. Tuck L, Astala R, Reid JW, Sayer M, Stott MJ. Dissolution and re-crystallization processes in multiphase silicon stabi-
lized tricalcium phosphate. J Mater Sci Mater Med. 2008;19(2):917–27.
Page 14 of 14Sun et al. BioMed Eng OnLine  (2015) 14:47 
 26. Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Inj Int J Care Inj. 
2000;31:S37–47.
 27. Suchanek W, Yashima M, Kakihana M, Yoshimura M. Processing and mechanical properties of hydroxyapatite rein-
forced with hydroxyapatite whiskers. Biomaterials. 1996;17(17):1715–23.
 28. Patel N, Brooks RA, Clarke MT, Lee PM, Rushton N, Gibson IR, et al. In vivo assessment of hydroxyapatite and silicate-
substituted hydroxyapatite granules using an ovine defect model. J Mater Sci Mater Med. 2005;16(5):429–40.
 29. Samachson J. Basic requirements for calcification. Nature. 1969;221(5187):1247–8.
 30. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;27(15):2907–15.
 31. Loty C, Sautier JM, Boulekbache H, Kokubo T, Kim HM, Forest N. In vitro bone formation on a bone-like apatite layer 
prepared by a biomimetic process on a bioactive glass-ceramic. J Biomed Mater Res. 2000;49(4):423–34.
 32. Pilliar RM, Filiaggi MJ, Wells JD, Grynpas MD, Kandel RA. Porous calcium polyphosphate scaffolds for bone substitute 
applications—in vitro characterization. Biomaterials. 2001;22(9):963–72.
 33. Deb S, Braden M, Bonfield W. Water absorption characteristics of modified hydroxyapatite bone cements. Biomateri-
als. 1995;16(14):1095–100.
 34. Lockington DA, Parlange JY. Anomalous water absorption in porous materials. J Phys D Appl Phys. 2003;36:760–7.
 35. Liu X, Huang W, Fu H, Yao A, Wang D, Pan H, et al. Bioactive borosilicate glass scaffolds: in vitro degradation and 
bioactivity behaviors. J Mater Sci Mater Med. 2009;20(6):1237–43.
 36. Shore EC, Holmes E. Porous hydroxyapatite. Singapore: World Scientific; 1993.
 37. Yuan H, Kurashina K, de Bruijn JD, Li Y, de Groot K, Zhang X. A preliminary study on osteoinduction of two kinds of 
calcium phosphate ceramics. Biomaterials. 1999;20(19):1799–806.
 38. Zhang F, Chang J, Lin K, Lu J. Preparation, mechanical properties and in vitro degradability of wollastonite/tricalcium 
phosphate macroporous scaffolds from nanocomposite powders. J Mater Sci Mater Med. 2008;19(1):167–73.
 39. Kang Y, Yao Y, Yin G, Huang Z, Liao X, Xu X, et al. A study on the in vitro degradation properties of poly(l-lactic acid)/
beta-tricalcuim phosphate (PLLA/beta-TCP) scaffold under dynamic loading. Med Eng Phys. 2009;31(5):589–94.
 40. Zhuang HY, Han Y, Feng AL. Preparation, mechanical properties and in vitro biodegradation of porous magnesium 
scaffolds. Mat Sci Eng C Bio S. 2008;28(8):1462–6.
 41. Shen J, Li Y, Zuo Y, Zou Q, Cheng L, Zhang L, et al. Characterization and cytocompatibility of biphasic calcium phos-
phate/polyamide 6 scaffolds for bone regeneration. J Biomed Mater Res B Appl Biomater. 2010;95(2):330–8.
 42. Lu JX, Flautre B, Anselme K, Hardouin P, Gallur A, Descamps M, et al. Role of interconnections in porous bioceramics 
on bone recolonization in vitro and in vivo. J Mater Sci Mater Med. 1999;10(2):111–20.
 43. Sanchez-Salcedo S, Nieto A, Vallet-Regi M. Hydroxyapatite/β-tricalcium phosphate/agarose macroporous scaffolds 
for bone tissue engineering. Chem Eng J. 2008;137:62–71.
 44. Sánchez-Salcedo S, Arcos D, Vallet-Regí M. Upgrading calcium phosphate scaffolds for tissue engineering applica-
tions. Key Eng Mater. 2008;377:19–42.
 45. Oyane A, Kawashita M, Nakanishi K, Kokubo T, Minoda M, Miyamoto T, et al. Bonelike apatite formation on eth-
ylene–vinyl alcohol copolymer modified with silane coupling agent and calcium silicate solutions. Biomaterials. 
2003;24(10):1729–35.
 46. Wang XT, Zhou CL, Yan JL, Yan X, Xie HX, Sun CL. The fate of donor osteocytes in fine particulate bone powders dur-
ing repair of bone defects in experimental rats. Acta Histochem. 2012;114(3):192–8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
